US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 1.890
  • -0.080-4.06%
Close Dec 27 16:00 ET
  • 1.899
  • +0.009+0.49%
Post 20:01 ET
155.85MMarket Cap-1.22P/E (TTM)

Sutro Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-92.57%-64.52M
130.31%9.46M
-6.15%-64.74M
-3,245.00%-111.62M
158.97%14.07M
-150.87%-33.5M
-879.13%-31.2M
-73.00%-60.99M
104.35%3.55M
-10.58%-23.86M
Net income from continuing operations
1.01%-48.79M
-24.64%-48.02M
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
Depreciation and amortization
3.45%1.8M
3.41%1.79M
9.04%1.76M
19.79%6.82M
13.29%1.73M
20.93%1.74M
23.91%1.73M
21.70%1.62M
17.46%5.69M
16.20%1.53M
Other non cash items
27.21%9.4M
617.39%8.79M
1,268.47%8.59M
475.63%16.82M
835.93%7.58M
854.26%7.39M
125.18%1.23M
-20.91%628K
-52.56%2.92M
-55.95%810K
Change In working capital
-290.27%-7.12M
514.23%48.37M
31.93%-16.62M
-132.92%-34.38M
-210.30%-21.58M
-95.32%3.74M
-21.92%7.88M
-367.38%-24.41M
692.54%104.41M
524.68%19.57M
-Change in receivables
104.45%295K
19,425.40%24.35M
273.68%4.78M
-642.15%-28.96M
-571.20%-19.45M
-107.67%-6.63M
99.85%-126K
-458.20%-2.75M
177.46%5.34M
3,429.03%4.13M
-Change in prepaid assets
-393.20%-2.55M
-95.83%306K
67.81%-2.39M
103.08%109K
-10.95%-669K
130.35%868K
2,603.07%7.33M
-3,601.89%-7.42M
10.48%-3.54M
-204.87%-603K
-Change in payables and accrued expense
-127.88%-1.35M
-323.37%-6.01M
-20.95%-2.66M
464.21%30.11M
476.77%24.78M
658.59%4.84M
-19.30%2.69M
-54.13%-2.2M
-37.75%5.34M
5.04%4.3M
-Change in other current liabilities
-16.88%-1.66M
-79.23%-1.55M
-79.57%-1.5M
-341.57%-4.59M
-398.78%-1.46M
-396.25%-1.42M
-280.71%-862K
-285.59%-837K
169.60%1.9M
125.98%490K
-Change in other working capital
-130.55%-1.86M
2,788.99%31.27M
-32.51%-14.84M
-132.56%-31.06M
-320.14%-24.78M
289.68%6.08M
-101.26%-1.16M
-114.27%-11.2M
856.15%95.37M
2,259.33%11.25M
Cash from discontinued investing activities
Operating cash flow
-92.57%-64.52M
130.31%9.46M
-6.15%-64.74M
-3,245.00%-111.62M
158.97%14.07M
-150.87%-33.5M
-879.13%-31.2M
-73.00%-60.99M
104.35%3.55M
-10.58%-23.86M
Investing cash flow
Cash flow from continuing investing activities
229.18%147.29M
-221.49%-80.38M
-4.96%64.11M
88.80%-3.92M
37.93%-23.51M
-46.11%-114.02M
38.07%66.16M
104.51%67.45M
64.01%-35.02M
-282.29%-37.88M
Net PPE purchase and sale
-152.44%-828K
52.87%-756K
52.65%-446K
45.09%-4.32M
57.20%-1.44M
55.56%-328K
27.09%-1.6M
39.34%-942K
48.72%-7.86M
-32.72%-3.37M
Net investment purchase and sale
230.28%148.12M
-217.50%-79.62M
-5.62%64.55M
101.44%391K
36.07%-22.07M
-47.08%-113.69M
35.21%67.76M
98.04%68.39M
66.86%-27.17M
-248.11%-34.52M
Net other investing changes
----
----
----
----
----
----
----
----
0.00%9K
----
Cash from discontinued investing activities
Investing cash flow
229.18%147.29M
-221.49%-80.38M
-4.96%64.11M
88.80%-3.92M
37.93%-23.51M
-46.11%-114.02M
38.07%66.16M
104.51%67.45M
64.01%-35.02M
-282.29%-37.88M
Financing cash flow
Cash flow from continuing financing activities
117.72%1.02M
-29.91%96.49M
-139.15%-3.43M
184.71%137.55M
-125.57%-3.13M
-119.23%-5.74M
2,409.77%137.66M
1,052.37%8.76M
1,383.81%48.31M
2,315.22%12.22M
Net issuance payments of debt
--0
--0
-30.66%-4.08M
-33.33%-12.5M
0.00%-3.13M
0.00%-3.13M
0.00%-3.13M
---3.13M
---9.38M
---3.13M
Net common stock issuance
--0
9,110.59%96.53M
--0
-78.73%11.97M
--0
--0
-87.81%1.05M
--10.92M
803,957.14%56.27M
219,314.29%15.35M
Proceeds from stock option exercised by employees
14.36%1.09M
--0
-27.14%1.03M
25.73%2.37M
--0
37.86%954K
--0
18.97%1.41M
-55.74%1.88M
-99.81%1K
Net other financing activities
97.93%-74K
-100.03%-37K
17.07%-374K
29,412.74%135.72M
--0
-7,038.00%-3.57M
1,074,807.69%139.74M
-5.87%-451K
53.09%-463K
--0
Cash from discontinued financing activities
Financing cash flow
117.72%1.02M
-29.91%96.49M
-139.15%-3.43M
184.71%137.55M
-125.57%-3.13M
-119.23%-5.74M
2,409.77%137.66M
1,052.37%8.76M
1,383.81%48.31M
2,315.22%12.22M
Net cash flow
Beginning cash position
-61.16%91.65M
4.31%66.08M
45.74%70.14M
53.83%48.13M
-15.30%82.71M
195.01%235.97M
112.76%63.34M
53.83%48.13M
-84.89%31.29M
209.23%97.65M
Current changes in cash
154.67%83.79M
-85.19%25.57M
-126.71%-4.07M
30.72%22.01M
74.63%-12.57M
-967.65%-153.26M
243.77%172.62M
1,105.82%15.22M
109.58%16.84M
-16,802.73%-49.53M
End cash Position
112.12%175.44M
-61.16%91.65M
4.31%66.08M
45.74%70.14M
45.74%70.14M
-15.30%82.71M
195.01%235.97M
112.76%63.34M
53.83%48.13M
53.83%48.13M
Free cash flow
-93.15%-65.34M
126.52%8.7M
-5.25%-65.19M
-2,590.44%-115.93M
146.38%12.63M
-151.95%-33.83M
-508.97%-32.8M
-68.26%-61.93M
95.56%-4.31M
-12.91%-27.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -92.57%-64.52M130.31%9.46M-6.15%-64.74M-3,245.00%-111.62M158.97%14.07M-150.87%-33.5M-879.13%-31.2M-73.00%-60.99M104.35%3.55M-10.58%-23.86M
Net income from continuing operations 1.01%-48.79M-24.64%-48.02M-16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M
Depreciation and amortization 3.45%1.8M3.41%1.79M9.04%1.76M19.79%6.82M13.29%1.73M20.93%1.74M23.91%1.73M21.70%1.62M17.46%5.69M16.20%1.53M
Other non cash items 27.21%9.4M617.39%8.79M1,268.47%8.59M475.63%16.82M835.93%7.58M854.26%7.39M125.18%1.23M-20.91%628K-52.56%2.92M-55.95%810K
Change In working capital -290.27%-7.12M514.23%48.37M31.93%-16.62M-132.92%-34.38M-210.30%-21.58M-95.32%3.74M-21.92%7.88M-367.38%-24.41M692.54%104.41M524.68%19.57M
-Change in receivables 104.45%295K19,425.40%24.35M273.68%4.78M-642.15%-28.96M-571.20%-19.45M-107.67%-6.63M99.85%-126K-458.20%-2.75M177.46%5.34M3,429.03%4.13M
-Change in prepaid assets -393.20%-2.55M-95.83%306K67.81%-2.39M103.08%109K-10.95%-669K130.35%868K2,603.07%7.33M-3,601.89%-7.42M10.48%-3.54M-204.87%-603K
-Change in payables and accrued expense -127.88%-1.35M-323.37%-6.01M-20.95%-2.66M464.21%30.11M476.77%24.78M658.59%4.84M-19.30%2.69M-54.13%-2.2M-37.75%5.34M5.04%4.3M
-Change in other current liabilities -16.88%-1.66M-79.23%-1.55M-79.57%-1.5M-341.57%-4.59M-398.78%-1.46M-396.25%-1.42M-280.71%-862K-285.59%-837K169.60%1.9M125.98%490K
-Change in other working capital -130.55%-1.86M2,788.99%31.27M-32.51%-14.84M-132.56%-31.06M-320.14%-24.78M289.68%6.08M-101.26%-1.16M-114.27%-11.2M856.15%95.37M2,259.33%11.25M
Cash from discontinued investing activities
Operating cash flow -92.57%-64.52M130.31%9.46M-6.15%-64.74M-3,245.00%-111.62M158.97%14.07M-150.87%-33.5M-879.13%-31.2M-73.00%-60.99M104.35%3.55M-10.58%-23.86M
Investing cash flow
Cash flow from continuing investing activities 229.18%147.29M-221.49%-80.38M-4.96%64.11M88.80%-3.92M37.93%-23.51M-46.11%-114.02M38.07%66.16M104.51%67.45M64.01%-35.02M-282.29%-37.88M
Net PPE purchase and sale -152.44%-828K52.87%-756K52.65%-446K45.09%-4.32M57.20%-1.44M55.56%-328K27.09%-1.6M39.34%-942K48.72%-7.86M-32.72%-3.37M
Net investment purchase and sale 230.28%148.12M-217.50%-79.62M-5.62%64.55M101.44%391K36.07%-22.07M-47.08%-113.69M35.21%67.76M98.04%68.39M66.86%-27.17M-248.11%-34.52M
Net other investing changes --------------------------------0.00%9K----
Cash from discontinued investing activities
Investing cash flow 229.18%147.29M-221.49%-80.38M-4.96%64.11M88.80%-3.92M37.93%-23.51M-46.11%-114.02M38.07%66.16M104.51%67.45M64.01%-35.02M-282.29%-37.88M
Financing cash flow
Cash flow from continuing financing activities 117.72%1.02M-29.91%96.49M-139.15%-3.43M184.71%137.55M-125.57%-3.13M-119.23%-5.74M2,409.77%137.66M1,052.37%8.76M1,383.81%48.31M2,315.22%12.22M
Net issuance payments of debt --0--0-30.66%-4.08M-33.33%-12.5M0.00%-3.13M0.00%-3.13M0.00%-3.13M---3.13M---9.38M---3.13M
Net common stock issuance --09,110.59%96.53M--0-78.73%11.97M--0--0-87.81%1.05M--10.92M803,957.14%56.27M219,314.29%15.35M
Proceeds from stock option exercised by employees 14.36%1.09M--0-27.14%1.03M25.73%2.37M--037.86%954K--018.97%1.41M-55.74%1.88M-99.81%1K
Net other financing activities 97.93%-74K-100.03%-37K17.07%-374K29,412.74%135.72M--0-7,038.00%-3.57M1,074,807.69%139.74M-5.87%-451K53.09%-463K--0
Cash from discontinued financing activities
Financing cash flow 117.72%1.02M-29.91%96.49M-139.15%-3.43M184.71%137.55M-125.57%-3.13M-119.23%-5.74M2,409.77%137.66M1,052.37%8.76M1,383.81%48.31M2,315.22%12.22M
Net cash flow
Beginning cash position -61.16%91.65M4.31%66.08M45.74%70.14M53.83%48.13M-15.30%82.71M195.01%235.97M112.76%63.34M53.83%48.13M-84.89%31.29M209.23%97.65M
Current changes in cash 154.67%83.79M-85.19%25.57M-126.71%-4.07M30.72%22.01M74.63%-12.57M-967.65%-153.26M243.77%172.62M1,105.82%15.22M109.58%16.84M-16,802.73%-49.53M
End cash Position 112.12%175.44M-61.16%91.65M4.31%66.08M45.74%70.14M45.74%70.14M-15.30%82.71M195.01%235.97M112.76%63.34M53.83%48.13M53.83%48.13M
Free cash flow -93.15%-65.34M126.52%8.7M-5.25%-65.19M-2,590.44%-115.93M146.38%12.63M-151.95%-33.83M-508.97%-32.8M-68.26%-61.93M95.56%-4.31M-12.91%-27.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.